ICON PLC (ICLR) Stock Fundamental Analysis
USA - NASDAQ:ICLR - IE0005711209 - Common Stock
163.42 USD
0 (0%)
163.42 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to ICLR. ICLR was compared to 58 industry peers in the Life Sciences Tools & Services industry. ICLR has an average financial health and profitability rating. ICLR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make ICLR suitable for value investing!
1. Profitability
1.1 Basic Checks
ICLR had positive earnings in the past year.
In the past year ICLR had a positive cash flow from operations.
Each year in the past 5 years ICLR has been profitable.
In the past 5 years ICLR always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 3.63%, ICLR is doing good in the industry, outperforming 75.86% of the companies in the same industry.
ICLR has a Return On Equity of 6.42%. This is in the better half of the industry: ICLR outperforms 75.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.74%, ICLR is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICLR is significantly below the industry average of 13.50%.
The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROIC | 6.74% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
ICLR has a better Profit Margin (7.40%) than 75.86% of its industry peers.
ICLR's Profit Margin has declined in the last couple of years.
ICLR has a better Operating Margin (13.99%) than 75.86% of its industry peers.
In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
ICLR has a Gross Margin of 28.15%. This is in the lower half of the industry: ICLR underperforms 74.14% of its industry peers.
ICLR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICLR is destroying value.
The number of shares outstanding for ICLR has been reduced compared to 1 year ago.
ICLR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ICLR has an improved debt to assets ratio.
2.2 Solvency
ICLR has an Altman-Z score of 1.99. This is not the best score and indicates that ICLR is in the grey zone with still only limited risk for bankruptcy at the moment.
ICLR has a Altman-Z score of 1.99. This is comparable to the rest of the industry: ICLR outperforms 53.45% of its industry peers.
ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
ICLR's Debt to FCF ratio of 3.53 is fine compared to the rest of the industry. ICLR outperforms 79.31% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that ICLR is not too dependend on debt financing.
ICLR's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. ICLR outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Altman-Z | 1.99 |
ROIC/WACC0.8
WACC8.38%
2.3 Liquidity
ICLR has a Current Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.06, ICLR is doing worse than 86.21% of the companies in the same industry.
A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.06, ICLR is doing worse than 77.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
The earnings per share for ICLR have decreased by -5.99% in the last year.
Measured over the past years, ICLR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.23% on average per year.
ICLR shows a decrease in Revenue. In the last year, the revenue decreased by -2.46%.
The Revenue has been growing by 24.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
3.2 Future
ICLR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.61% yearly.
ICLR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.38% yearly.
EPS Next Y-4.67%
EPS Next 2Y-0.67%
EPS Next 3Y3%
EPS Next 5Y5.61%
Revenue Next Year-2.45%
Revenue Next 2Y-0.8%
Revenue Next 3Y0.9%
Revenue Next 5Y2.38%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.39, which indicates a correct valuation of ICLR.
Based on the Price/Earnings ratio, ICLR is valued cheaper than 96.55% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. ICLR is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 11.83, the valuation of ICLR can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ICLR is valued cheaper than 98.28% of the companies in the same industry.
ICLR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.43.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.39 | ||
| Fwd PE | 11.83 |
4.2 Price Multiples
ICLR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICLR is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICLR is valued cheaper than 96.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.18 | ||
| EV/EBITDA | 10.28 |
4.3 Compensation for Growth
ICLR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.81
EPS Next 2Y-0.67%
EPS Next 3Y3%
5. Dividend
5.1 Amount
No dividends for ICLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
163.42
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.62%
Inst Owner Change0.28%
Ins Owners0.65%
Ins Owner ChangeN/A
Market Cap12.71B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts76.67
Price Target212.57 (30.08%)
Short Float %2.91%
Short Ratio2.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-3.43%
PT rev (3m)-4.08%
EPS NQ rev (1m)-4.78%
EPS NQ rev (3m)-6.16%
EPS NY rev (1m)-1.07%
EPS NY rev (3m)-1.31%
Revenue NQ rev (1m)1.03%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.39 | ||
| Fwd PE | 11.83 | ||
| P/S | 1.57 | ||
| P/FCF | 13.18 | ||
| P/OCF | 11.14 | ||
| P/B | 1.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.28 |
EPS(TTM)13.19
EY8.07%
EPS(NY)13.81
Fwd EY8.45%
FCF(TTM)12.4
FCFY7.59%
OCF(TTM)14.66
OCFY8.97%
SpS104.19
BVpS120.03
TBVpS-38.28
PEG (NY)N/A
PEG (5Y)0.81
Graham Number188.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 176.34% | ||
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% | ||
| FCFM | 11.9% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 45.31% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.92% | ||
| Profit Quality | 160.84% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 1.99 |
F-Score6
WACC8.38%
ROIC/WACC0.8
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-4.67%
EPS Next 2Y-0.67%
EPS Next 3Y3%
EPS Next 5Y5.61%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.45%
Revenue Next 2Y-0.8%
Revenue Next 3Y0.9%
Revenue Next 5Y2.38%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.82%
EBIT Next 3Y3.29%
EBIT Next 5Y4.34%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%
ICON PLC / ICLR FAQ
Can you provide the ChartMill fundamental rating for ICON PLC?
ChartMill assigns a fundamental rating of 5 / 10 to ICLR.
What is the valuation status of ICON PLC (ICLR) stock?
ChartMill assigns a valuation rating of 7 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.
Can you provide the profitability details for ICON PLC?
ICON PLC (ICLR) has a profitability rating of 6 / 10.
How financially healthy is ICON PLC?
The financial health rating of ICON PLC (ICLR) is 5 / 10.
What is the earnings growth outlook for ICON PLC?
The Earnings per Share (EPS) of ICON PLC (ICLR) is expected to decline by -4.67% in the next year.